drugset / Trial / NCT02641730
An Efficacy and Safety of Guselkumab in Participants With Palmoplantar Pustulosis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of guselkumab for the treatment of participants with palmoplantar pustulosis.
Timeline
- Start
- 2015-12-15
- Primary completion
- 2017-03-28
- Completion
- 2018-07-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Guselkumab | Monoclonal antibody | 100 mg | Subcutaneous |
| Subject | Guselkumab | Monoclonal antibody | 200 mg | Subcutaneous |